Biotechnology Reproductive Tissue Ownership Law In Russia.

1. Introduction

Biotechnology Reproductive Tissue Ownership Law in Russia concerns the legal rights, responsibilities and regulatory restrictions relating to the collection, preservation, storage, use, transfer and disposal of human reproductive materials.

Reproductive tissues and materials primarily include:

Human sperm and semen.

Oocytes (human eggs).

Ovarian tissue.

Testicular tissue.

Fertilised embryos.

Cryopreserved reproductive cells.

Reproductive biological samples used in assisted reproductive technologies (ART).

Genetic materials collected for reproductive research.

The subject becomes particularly important in cases involving in-vitro fertilisation (IVF), fertility preservation, surrogacy, posthumous reproduction, embryo disputes, reproductive tissue donation and commercial biotechnology.

A fundamental legal distinction: Russian law does not establish an unrestricted ordinary property right over human reproductive tissue. Instead, it regulates these materials through constitutional rights, medical consent, reproductive autonomy, healthcare legislation, donor rules and contractual obligations.

Consequently, a person may possess important rights concerning the use and preservation of their reproductive materials without necessarily having unrestricted ownership rights equivalent to ownership of ordinary commercial property.

2. Legal Framework Governing Reproductive Tissue Ownership

Russia does not have one comprehensive statute exclusively dedicated to reproductive tissue ownership. The applicable framework consists of several interconnected legal instruments.

A. Constitution of the Russian Federation

The Constitution provides the foundation for reproductive autonomy and protection of human dignity.

Important provisions include:

Article 21: Protection of human dignity.

Article 23: Protection of privacy and personal and family secrets.

Article 24: Restrictions on collecting, storing and disseminating information concerning private life without consent, subject to constitutional and statutory rules.

Article 35: Protection of property rights.

Article 41: Right to healthcare and medical assistance.

These provisions are relevant when disputes arise concerning the unauthorized collection, storage, disclosure or use of reproductive biological materials.

Article 35 should not, however, be interpreted as automatically converting human reproductive tissue into ordinary privately owned property.

B. Federal Law No. 323-FZ of 21 November 2011

The Federal Law On the Fundamentals of Health Protection of Citizens in the Russian Federation is one of the most important statutes governing reproductive tissue.

Relevant provisions include:

Article 19: Patient rights.

Article 20: Informed voluntary consent to medical intervention and refusal of medical intervention.

Article 22: Information about health conditions and medical information.

Article 55: Application of assisted reproductive technologies.

Article 55 is particularly important because it establishes the statutory framework for assisted reproductive technologies, including the use of reproductive cells and embryos.

It provides the foundation for regulating reproductive treatment, donor participation and the use of reproductive materials.

C. Russian Civil Code

The Civil Code becomes relevant when reproductive tissue disputes involve contracts, compensation, medical-service obligations, damages and contractual liability.

Relevant provisions include:

Article 150: Intangible benefits.

Article 151: Compensation for moral harm.

Article 152.2: Protection of information concerning private life.

Articles 307–309: Obligations and their proper performance.

Article 1064: General principles of compensation for harm.

Article 1099: General provisions concerning compensation for moral harm.

The Civil Code can provide remedies when a fertility clinic improperly stores, handles, transfers or destroys reproductive materials.

However, contractual rights over storage services should not automatically be confused with ownership of the human biological material itself.

D. Ministry of Health Order No. 803n of 31 July 2020

This Order establishes the procedure for using assisted reproductive technologies in Russia.

It is particularly important for reproductive tissue ownership disputes.

Its provisions address:

Collection of sperm and oocytes.

Cryopreservation of reproductive cells.

Storage of reproductive tissues and embryos.

Use of donor reproductive materials.

Medical consent.

Decisions concerning unused reproductive materials.

Donation, continued storage and disposal.

Paragraph 18 is especially significant. It provides for decisions concerning the future of unused reproductive cells and embryos, including donation, cryopreservation and disposal, through the relevant civil-law arrangements made by the persons to whom the materials belong.

Paragraph 30 regulates the medical organisations that perform cryopreservation and storage. Such activities must be undertaken by appropriately licensed medical organisations with suitable facilities.

This creates an important distinction between the patient's rights concerning the material and the clinic's responsibility for its safekeeping.

3. Legal Nature of Reproductive Tissue: Ownership or Personal Rights?

One of the most complicated questions in Russian biotechnology law is whether human reproductive materials constitute property under civil law.

There are three important legal approaches.

1. Property-based approach

Under this approach, reproductive materials may be treated as objects over which individuals exercise certain rights of possession, use and disposal.

For example, an individual may arrange for sperm or oocytes to be cryopreserved and subsequently used in fertility treatment.

2. Personal-rights approach

Under this approach, reproductive tissue is closely connected with bodily integrity, privacy, reproductive autonomy and personal identity.

It cannot simply be treated as an ordinary commercial commodity.

3. Special biological-material approach

This approach recognises that reproductive materials require a special legal regime combining:

Personal consent.

Medical regulation.

Reproductive rights.

Contractual arrangements.

Restrictions on commercial exploitation.

Protection against unauthorised use.

Russian legal scholarship has strongly discussed this third approach.

An important academic contribution is D. A. Belova's article, The Legal Regime of Reproductive Biological Material (2021). It argues that reproductive biological material should not be classified as an ordinary thing and that applying the ordinary property-rights regime to human reproductive cells and reproductive-organ tissues is inappropriate.

crimescience.ru

 

Legal conclusion: Russian legislation recognises certain rights of individuals over reproductive materials, but those rights should not be confused with unrestricted ownership under the ordinary law of property.

4. Ownership Rights Over Different Types of Reproductive Materials

A. Sperm Ownership and Legal Control

Sperm is one of the most commonly preserved reproductive materials.

Russian law permits individuals to preserve their sperm for future reproductive purposes.

A man may arrange for:

Collection of sperm.

Cryopreservation.

Long-term storage.

Future use in IVF.

Use in other authorised reproductive procedures.

Donation under the applicable legal arrangements.

The individual has important rights concerning the authorised use of his reproductive material.

However, the clinic cannot assume that the right to store sperm automatically gives it the right to use that sperm for another person's reproductive treatment.

Informed consent and the applicable agreements are essential.

B. Oocyte Ownership

Oocytes are human reproductive cells collected from the ovaries.

Their collection and preservation are particularly relevant for:

Fertility preservation.

Cancer patients undergoing treatment.

Women delaying pregnancy.

IVF treatment.

Donor-oocyte programmes.

Under Article 55 of Federal Law No. 323-FZ, citizens have the right to cryopreservation and storage of their reproductive cells.

The individual whose oocytes are preserved has legally significant rights concerning their future reproductive use.

A fertility clinic cannot treat the oocytes as its freely disposable commercial assets merely because it has collected and stored them.

C. Ovarian and Testicular Tissue

Ovarian and testicular tissues may be preserved to protect future fertility.

These procedures are especially relevant when medical treatment may destroy reproductive function.

For example:

A cancer patient may preserve ovarian tissue before chemotherapy.

A patient may preserve testicular tissue before treatment that threatens fertility.

Reproductive tissue may be stored for medically authorised future use.

Article 55 expressly includes tissues of reproductive organs within its framework.

The relevant medical consent, storage agreement and applicable technical requirements govern the relationship between the patient and the medical organisation.

D. Frozen Embryo Ownership

'Anxiety and concern' as Auckland fertility clinic loses patient's embryos

 

 

Criopreservación | Equinova

 

 

Что происходит в эмбриологической лаборатории? Энциклопедия Клиники ЭКО

 

8

 

Frozen embryos create more complicated ownership disputes than sperm or oocytes because they contain genetic material from one or more individuals and have potential reproductive significance.

Questions include:

Who can decide whether an embryo should be implanted?

Can one partner use an embryo after divorce?

What happens if one genetic contributor dies?

Can embryos be donated?

Can embryos be destroyed without consent?

Can embryos be inherited?

Can a fertility clinic refuse to release stored embryos?

Russian law approaches these questions through Article 55 of Federal Law No. 323-FZ, Order No. 803n, medical consent and relevant civil and family law provisions.

The legal rights of the individuals who provided the reproductive materials are particularly important.

However, an embryo should not automatically be treated as ordinary inheritable property.

5. Consent and Control Over Reproductive Tissue

Consent is one of the most important principles of Russian reproductive tissue regulation.

Article 20 of Federal Law No. 323-FZ establishes informed voluntary consent as a prerequisite for medical intervention, subject to statutory exceptions.

Article 55 specifically regulates consent for assisted reproductive technologies.

Consent should address the nature and purpose of the treatment, its risks and the proposed use of reproductive materials.

For practical legal protection, fertility clinics should maintain written records concerning:

The identity of the person providing the material.

The type of reproductive material collected.

The purpose of collection.

The period and conditions of storage.

The authorised future use.

Donation arrangements.

Disposal instructions.

Procedures following death or loss of legal capacity.

A dispute may arise if a clinic uses reproductive material beyond the scope of the consent provided.

Such conduct may create civil liability and potentially regulatory consequences.

6. Can Reproductive Tissue Be Sold or Commercially Exploited?

Russian law imposes significant restrictions on commercial exploitation of human reproductive materials.

Article 55(6) of Federal Law No. 323-FZ expressly states that human reproductive cells, tissues of reproductive organs and embryos cannot be used for industrial purposes.

minzdrav.gov.ru+1

 

This restriction is important for biotechnology companies and fertility clinics.

It distinguishes between:

Charging for legitimate medical services.

Charging for cryopreservation and storage.

Lawfully organised donor arrangements.

Industrial exploitation of human reproductive materials.

A clinic may charge for authorised medical and storage services. That does not mean it acquires unrestricted ownership of the stored materials.

Similarly, payment for medical services does not itself establish a right to sell or commercially exploit a patient's reproductive tissue.

7. Inheritance and Posthumous Reproductive Tissue Rights

Inheritance is one of the most controversial aspects of reproductive tissue ownership.

Consider the following hypothetical situation:

A man preserves sperm before undergoing cancer treatment. He subsequently dies. His spouse wants to use the preserved sperm to conceive a child.

The legal questions include:

Does the sperm form part of the deceased's estate?

Can the surviving spouse use it?

Is posthumous reproductive consent required?

Can the deceased's parents claim the sperm?

Can the material be transferred to another fertility clinic?

Russian law does not establish an unrestricted inheritance right over reproductive biological material.

The deceased person's consent, the purpose of storage and the applicable medical and contractual arrangements are central.

The distinction between inheritance of property and permission to use reproductive material is particularly important.

A family member cannot simply assume that becoming an heir gives them the right to use another person's reproductive tissue.

8. Important Russian Case Laws on Reproductive Tissue Ownership

The following judicial decisions illustrate how Russian courts approach disputes involving reproductive materials, embryos, consent, storage and reproductive rights.

Case 1. Supreme Court of the Russian Federation — 2 July 2019, No. 64-КГ19-6

Supreme Court decision

Subject: Donor genetic material and parental rights

In this case, a woman sought to establish paternity and obtain child maintenance from a man whose genetic material had been used in assisted reproduction.

The parties were not married. The man had provided genetic material as a donor and had not undertaken parental responsibilities.

The Supreme Court considered the relevant provisions of Article 55 of Federal Law No. 323-FZ and the rules governing donor-assisted reproduction.

The Court overturned the appellate decision and restored the first-instance judgment rejecting the claims.

Legal principles:

A genetic donor does not automatically acquire parental rights and obligations.

The legal status of a donor must be distinguished from that of an intended parent.

The use of donated genetic material does not automatically establish legal paternity.

Reproductive consent and donor status are legally significant.

Relevance to tissue ownership: Providing reproductive material does not automatically create unrestricted parental or property rights over a resulting child or reproductive arrangement.

Source:

ГАРАНТ+1

 

Case 2. Simonovsky District Court, Moscow — 2025, Case No. 02-6663/2025

Important reproductive-material dispute

Subject: Rights concerning cryopreserved embryos and surrogacy

This dispute involved a married couple who had undergone IVF treatment using the husband's sperm and donor oocytes.

The couple had four cryopreserved embryos stored at a fertility clinic.

The dispute arose when the clinic refused to provide further surrogacy treatment using the stored embryos following changes to Russian legislation.

The applicants argued that they had previously created the embryos and should retain the ability to use them for reproductive purposes.

The court examined:

Article 55 of Federal Law No. 323-FZ.

Article 51 of the Russian Family Code.

Article 20 of Federal Law No. 323-FZ.

Ministry of Health Order No. 803n.

The legal effects of written reproductive consent.

The amendments introduced by Federal Law No. 538-FZ of 19 December 2022.

The decision is particularly important because it demonstrates the difference between rights concerning stored embryos and the legal eligibility to use those embryos in a particular reproductive programme.

Legal significance: Existing control over cryopreserved embryos does not automatically override subsequently applicable statutory restrictions on surrogacy.

The case also illustrates why the legal rights associated with stored embryos must be examined separately from the legal requirements governing the birth and registration of a child.

Source:

sudact.ru+1

 

Case 3. Russian First Cassation Court of General Jurisdiction — Reproductive Material Storage Dispute

Subject: Responsibility of fertility clinics for cryopreservation

This judicial material concerns the legal responsibilities of medical organisations storing reproductive cells, reproductive-organ tissues and embryos.

The court considered the requirements of Order No. 803n.

The relevant provisions establish that:

Medical organisations are responsible for appropriate storage.

Cryopreservation must comply with regulatory requirements.

Decisions concerning donation, continued preservation and disposal must follow the applicable consent and contractual procedures.

Legal principle: A fertility clinic is not free to dispose of stored reproductive materials merely because it physically possesses them.

This is particularly important where patients allege unauthorised destruction, transfer or misuse.

Source:

1kas.sudrf.ru

 

Case 4. Russian Court — 2026, Case No. 2-11076/2025, Judgment of 18 February 2026

Subject: Posthumous use of cryopreserved embryos

This case concerned a dispute involving a surviving woman seeking to establish her right to use cryopreserved embryos after the death of the other genetic contributor.

The applicant sought recognition of consent for assisted reproductive treatment and permission to proceed with embryo transfer.

The court considered whether the surviving person could establish a right to use the stored embryos based on the deceased person's earlier consent and the relevant medical arrangements.

The court distinguished between recognising a person's legal position and compelling a clinic to perform a particular medical procedure.

It did not grant the entire requested relief.

Legal significance:

Previous reproductive arrangements are important evidence.

Consent to storage does not necessarily establish consent to every future reproductive procedure.

Posthumous use requires careful examination of the deceased person's documented wishes and applicable law.

A clinic's contractual and medical obligations remain relevant.

Source:

sudact.ru

 

Case 5. Third Cassation Court of General Jurisdiction — 29 April 2026, No. 8Г-4098/2026

Inheritance and biological material

Subject: Whether reproductive biological material can be inherited

This decision addressed a claim by parents seeking rights over cryopreserved biological material belonging to their deceased child.

The lower courts had rejected the claim.

The reasoning was that the biological material did not constitute inheritable estate property and that the parents could not obtain the right to dispose of or use it merely by inheriting the deceased person's property.

The cassation proceedings concerned the application of:

Federal Law No. 323-FZ.

Law No. 4180-I concerning transplantation of human organs and tissues.

Ministry of Health Order No. 803n.

Civil-law inheritance principles.

Legal principle: Reproductive biological material does not automatically become inheritable property following the death of the person from whom it originated.

This is particularly significant for parents, spouses and other relatives attempting to obtain reproductive materials through inheritance proceedings.

Source:

ГАРАНТ

 

Case 6. Russian Court — 23 February 2025, Case No. 2-6712/2024

Subject: Consent, storage contracts and cryopreserved embryos

This case concerned cryopreserved embryos and the contractual relationship between patients and a fertility clinic.

The court considered informed voluntary consent, paid medical services and the legal significance of Order No. 803n.

It emphasised that the further treatment of unused reproductive materials, including donation, continued cryopreservation and disposal, must follow the relevant legal and contractual arrangements.

Legal principle: A patient's informed consent and the terms of the storage agreement are central to determining the permissible treatment of preserved embryos.

Source:

sudact.ru

 

9. Comparative Legal Position: Different Reproductive Materials

Reproductive materialMain legal consideration
SpermDonor consent and authorised future use
OocytesCollection, storage and reproductive consent
Ovarian tissueMedical preservation and future treatment
Testicular tissueMedical preservation and authorised use
Frozen embryosConsent of relevant contributors and reproductive arrangements
Donor embryosDonor rules and recipient consent
Posthumous reproductive materialDocumented wishes and applicable legal restrictions

The table reflects the general legal framework, not an assertion that every material has identical ownership status.

10. Legal Liability of Fertility Clinics

Fertility clinics have important legal responsibilities because they physically collect and preserve reproductive materials.

Their responsibilities include:

A. Unauthorised destruction

If a clinic destroys stored reproductive material without the legally required consent or other lawful basis, the affected person may seek compensation and other civil remedies.

B. Negligent cryopreservation

If improper storage causes damage to sperm, oocytes or embryos, the clinic may face contractual or tortious liability.

C. Unauthorised transfer

Transfer of reproductive materials to another organisation must comply with the applicable consent, medical and contractual requirements.

D. Unauthorised reproductive use

A clinic cannot assume that permission to store material automatically authorises its use in every future reproductive procedure.

E. Breach of confidentiality

Reproductive materials and associated genetic information raise serious privacy concerns. Unauthorised disclosure may engage medical confidentiality and personal-data protections.

Relevant legal provisions include Articles 20, 22, 55 and 98 of Federal Law No. 323-FZ and the applicable provisions of the Russian Civil Code.

11. Privacy and Genetic Data Protection

Reproductive tissue ownership disputes frequently overlap with genetic privacy.

For example, sperm and oocytes may contain genetic information that reveals:

Hereditary diseases.

Biological relationships.

Genetic ancestry.

Reproductive characteristics.

Family relationships.

The principal legislation includes:

Federal Law No. 152-FZ of 27 July 2006 on Personal Data.

Federal Law No. 323-FZ, particularly Article 13 concerning medical confidentiality.

Article 23 of the Russian Constitution.

Article 152.2 of the Russian Civil Code.

A fertility clinic must protect personal and medical information associated with reproductive samples.

The legal right to store a reproductive sample does not give the clinic unrestricted permission to disclose its genetic information.

12. International Case Laws Relevant to Russian Reproductive Tissue Ownership

International decisions provide useful comparative principles, particularly concerning embryos, reproductive autonomy and consent.

A. Evans v. United Kingdom (2007), European Court of Human Rights

Subject: Frozen embryos and withdrawal of consent

The case involved a woman who wanted to use frozen embryos created with her former partner.

The former partner withdrew his consent to their continued use.

The European Court of Human Rights examined the competing reproductive rights of both individuals under Article 8 of the European Convention on Human Rights.

Principle: The reproductive autonomy of one person must be balanced against the reproductive autonomy of the other.

Relevance to Russia: This is useful when analysing disagreements between genetic contributors concerning the continued storage or implantation of frozen embryos.

B. S.H. and Others v. Austria (2011), European Court of Human Rights

Subject: Assisted reproduction and reproductive rights

The case concerned restrictions on certain forms of assisted reproduction.

The Court examined the relationship between reproductive autonomy, private life and the state's regulatory authority.

Principle: States have a degree of discretion in regulating assisted reproductive technologies, but restrictions must be assessed against human rights requirements.

Relevance to Russia: It provides a comparative framework for assessing restrictions on reproductive biotechnology.

C. Paradiso and Campanelli v. Italy (2017), European Court of Human Rights

Subject: Surrogacy and biological relationships

This case involved an Italian couple who had used reproductive services in Russia.

A child was born through surrogacy in Moscow. The Italian authorities subsequently questioned the legal parentage arrangements because the child did not have an established biological relationship with the intended parents.

The Grand Chamber considered the matter under Article 8 of the European Convention on Human Rights.

Principle: Genetic relationships, intended parenthood, family life and the child's interests may require separate legal consideration.

Relevance to Russia: The case demonstrates the cross-border consequences of reproductive-material use and surrogacy arrangements.

Sources:

BAILII

 

These are comparative European human-rights decisions, not Russian domestic judgments establishing ownership rules. Their relevance must also be considered in light of Russia's withdrawal from the European Convention on Human Rights and the applicable temporal rules.

13. Major Legal Challenges in Russia

Several unresolved or complicated questions remain in reproductive tissue ownership law.

Legal challengePrincipal issue
Embryo ownershipWhether embryos should be treated as property or a special biological category
Divorce disputesWhich contributor may decide the future use of embryos
Posthumous reproductionWhether previously stored material can be used after death
InheritanceWhether reproductive material can pass to heirs
Donor anonymityBalancing privacy and genetic identity
Clinic bankruptcyProtection and transfer of stored materials
Cross-border transfersWhich country's rules govern reproductive samples
Biotechnology researchLimits on secondary use of reproductive material
Accidental destructionCompensation for loss of reproductive opportunities
Commercial exploitationLimits on the industrial use of human reproductive material

Particular problem: Clinic bankruptcy

Suppose a fertility clinic becomes insolvent while storing thousands of frozen embryos and reproductive samples.

Several questions arise:

Who is responsible for continued storage?

Can the materials be transferred to another licensed clinic?

Who pays the storage costs?

Can insolvency administrators treat the samples as ordinary assets?

How can patients recover control over their reproductive materials?

The better legal interpretation is that the clinic's contractual and custodial position does not give it unrestricted ownership of patients' reproductive materials.

However, detailed statutory procedures for every insolvency scenario remain an important area for legislative development.

14. Recommendations for Strengthening Russian Reproductive Tissue Ownership Law

Russia could improve its reproductive biotechnology framework through the following reforms.

1. Specific statutory recognition

A dedicated legal framework should clarify the distinction between ownership, custody, consent and reproductive decision-making.

2. Standardised storage agreements

All fertility clinics should use comprehensive agreements specifying storage periods, payment obligations, withdrawal of consent, disposal and transfer procedures.

3. Posthumous reproductive consent

Legislation should clarify whether reproductive material may be used following death and what form of advance consent is required.

4. Embryo dispute resolution

A specialised framework should address disagreements between genetic contributors, particularly following divorce or separation.

5. Stronger protection against unauthorised destruction

Clinics should maintain documented consent records and independently verifiable storage and disposal procedures.

6. Insolvency protection

A statutory continuity mechanism should protect patients when a fertility clinic closes or becomes insolvent.

7. Genetic privacy protection

Clearer rules should regulate access to, disclosure of and secondary use of genetic information derived from reproductive material.

15. Conclusion

Biotechnology Reproductive Tissue Ownership Law in Russia is an emerging and complex area of medical, civil, family and biotechnology law.

Its central legal principle is that human reproductive materials cannot simply be treated as ordinary commercial property.

Article 55 of Federal Law No. 323-FZ, Ministry of Health Order No. 803n and the Russian Civil Code establish a framework in which reproductive autonomy, informed consent, medical custody and contractual rights play essential roles.

Russian judicial decisions demonstrate several important developments:

The Supreme Court's 2019 decision distinguishes genetic donation from legal parenthood.

The 2025 Moscow decision illustrates the interaction between stored embryo rights and changing surrogacy legislation.

The 2026 cassation decision addresses the limits of inheritance claims over reproductive biological material.

Other disputes demonstrate the importance of consent, clinic responsibility and cryopreservation agreements.

Final legal position

The right to preserve, control and authorise the use of reproductive tissue is not equivalent to unrestricted ownership of ordinary property. Russian law increasingly recognises reproductive materials as a special category requiring protection through individual consent, medical regulation, reproductive autonomy and carefully defined legal arrangements.

16. Important Legal Sources for Further Research

Legal sourceSubject
Constitution of Russia, Articles 21, 23, 24, 35 and 41Dignity, privacy, property and healthcare
Federal Law No. 323-FZ (2011), Articles 19, 20, 22, 55 and 98Patient rights and reproductive technologies
Ministry of Health Order No. 803n (2020)ART and cryopreservation procedures
Russian Civil Code, Articles 150, 151, 307–309 and 1064Personal rights, obligations and liability
Russian Family Code, Articles 48 and 51Parentage and assisted reproduction
Federal Law No. 152-FZ (2006)Personal-data protection
Federal Law No. 538-FZ (2022)Changes to surrogacy legislation

Useful primary and judicial research links:

Federal Law No. 323-FZ — Russian Ministry of Health

Moscow District Court — Case No. 02-6663/2025

Russian Supreme Court — Case No. 64-КГ19-6

Third Cassation Court — Case No. 8Г-4098/2026

Legal Regime of Reproductive Biological Material — academic research

Academic note: The cited district and cassation judgments are individual decisions, not universally binding rules. The precise outcome of an individual dispute depends on the applicable statutory version, consent documents, contracts and facts. This explanation is for legal research and is not an individual legal opinion.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT